Verano Holdings (VRNO) Other Non-Current Assets (2021 - 2026)

Verano Holdings' (VRNO) quarterly Other Non-Current Assets came in at $10.0 million in Q1 2026, down 24.69% year-on-year from $13.3 million in Q1 2025, and down 5.21% on a QoQ basis from $10.6 million in Q4 2025.

Verano Holdings (VRNO) Other Non-Current Assets (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Other Non-Current Assets data on file, last reported at $10.0 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 24.69% year-over-year to $10.0 million in Q1 2026; TTM through Mar 2026 was $10.0 million, a 24.69% decrease from a year earlier, with the FY2025 full-year figure at $10.6 million, down 20.76% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $10.0 million, down from $10.6 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for VRNO reached as high as $14.0 million in Q2 2025 and fell as low as $2.6 million in Q2 2022.
  • Historically, Other Non-Current Assets has averaged $11.2 million across 5 years, with a median of $12.9 million in 2022.
  • Across the five-year window, Other Non-Current Assets soared 422.31% in 2023 and declined 24.69% in 2026, its largest moves.
  • Year by year, Other Non-Current Assets stood at $12.8 million in 2022, then fell by 3.27% to $12.3 million in 2023, then rose by 7.97% to $13.3 million in 2024, then declined by 20.76% to $10.6 million in 2025, then dropped by 5.21% to $10.0 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $10.0 million in Q1 2026, $10.6 million in Q4 2025, and $13.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn 10.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.02 Mn
Dec 31, 2025 10.57 Mn
Sep 30, 2025 13.14 Mn
Jun 30, 2025 14.00 Mn
Mar 31, 2025 13.30 Mn
Dec 31, 2024 13.33 Mn
Sep 30, 2024 13.07 Mn
Jun 30, 2024 11.28 Mn
Mar 31, 2024 10.50 Mn
Dec 31, 2023 12.35 Mn
Sep 30, 2023 13.82 Mn
Jun 30, 2023 13.31 Mn
Mar 31, 2023 13.33 Mn
Dec 31, 2022 12.77 Mn
Sep 30, 2022 2.65 Mn
Jun 30, 2022 2.58 Mn
Dec 31, 2021 2.50 Mn